Paola Grandi, PhD Birth Date - American Society of Gene & Cell ...

Božac A., Berto E., Garrafa E., Gardo G., Boccafogli L., Xausa M., Gavioli R., GRANDI P., Manservigi R., Marconi P.C.(2002). Replication defective HSV-1 vectors - a novel anti-tat vaccination strategy. In: 7th European Conference onExperimental AIDS Research-ECEARGRANDI P., Wang S., Schuback D., Krasnykh V., Spear M., Curiel D., Manservigi R., Breakefield X (2002). HSV-1amplicon vector engineered for specific binding to pseudo His-tag receptor. MOLECULAR THERAPY, ISSN: 1525-0024Bozac A., Berto E., Garrafa E., Gardo G., Xausa M., Boccafogli L., Gavioli R., GRANDI P., Manservigi R., Marconi P.(2002). Vettori erpetici non replicativi – vaccini innovativi contro tat. . In: 10th Congresso Nazionale S.I.M.M.O.CGrandi P. HSV-1 amplicon vector engineered for specific binding to pseudo his-tag receptor. Boston, Neurosurgery Dept.8 January 2003Grandi P. Sequential localization of two Herpes simplex virus tegument proteins to puntcate nuclear dots adjacent to ICP0domains. Boston, Harvard Medical School, Molecular Neurogenetics Dept. 6 June 2003GRANDI P., Samuel Wang, Deborah Schuback, Victor Krasnykh, Matthew Spear, David Curiel, Roberto Manservigi,Xandra Breakefield (2003). Amplicon Vector Engineered for Specific Binding to Pseudo His-Tag Receptor. In:International Herpesvirus Workshop 2003. Madison (USA), 26-31 luglio 2003Grandi P. Binding of HSV-1 vectors to a specific cell surface receptor. Can we image the infection process in vivo?Boston, Harvard Medical School, Molecular Neurogenetics Dept. 12 March 2004Grandi P. Oncolytic vectors:new strategies of tumor retargeting and imaging. University of Ferrara, Italy, 17 May 2004GRANDI P., Trevor McKee, Juliet L. Fernandez, Rakesh K. Jain, Xandra Breakefield (2004). New strategy to improvetumor infectibility of HSV-1 vectors in vivo. In: International Herpesvirus Workshop 2004. Reno, Nevada, USA, July2004Oehmig, Schuback D., GRANDI P., Fraefel C., Breakefield X (2004). Delivery of AAV REP proteins as VP16-REPfusion proteins in HSV-1 virions. In: International Herpesvirus Workshop 2004. Reno (Nevada-USA), July 25 - Friday,July 30GRANDI P., Wang S, Schuback D, Krasnykh V, Spear M, Curiel DT, Manservigi R, Breakefield XO (2004). HSV-1virions engineered for specific binding to cell surface receptors. MOLECULAR THERAPY, ISSN: 1525-0016GRANDI P. (2004). Binding of HSV-1 vectors to a specific cell surface receptor. Can we image the infection process invivo? , Invited speaker. University of Zurich, SwitzerlandGrandi P. Novel strategies for enhanced cancer therapy using HSV vectors. University of Pittsburgh, 13 December 2004GRANDI P. (2005). Binding of HSV-1 vectors to New Strategy to Improve Imaging and Retargeting of HSV-1 Vectors,Invited Speaker.American Society of Gene, Therapy, St. Louis, MOGRANDI P., McKee T, Mok W, Fernandez J, Breakefield X, Jain RK (2005). New Strategy To Improve Imaging andRetargeting of HSV-1 Vectors . MOLECULAR THERAPY, ISSN: 1525-0024GRANDI P., Trevor McKee, Juliet L. Fernandez, Rakesh K. Jain, Xandra Breakefield (2005). In vivo imaging ofcollagnease-enhanced hsv oncolytic vector destruction of solid tumors. In: International Herpesvirus Workshop 2005Turku, Finland, 30th July- 4th August6